AngioSoma, Inc.
15.7.2021 13:18:01 CEST | ACCESS Newswire | Press release
RICHLAND, WA / ACCESSWIRE / July 15, 2021 / GlobeStar Therapeutics Corporation has partnered with the Washington Football Team Yearbook producers for inclusion in their annual book.
GlobeStar Therapeutics Corporation (OTC PINK:GSTC) is partnering with the producers of the Washington Football Team Yearbook for inclusion in their 2021-2022 guide. The guide focuses on everything from players to partners to advertisers. GlobeStar will be seen in the guide which drops later this month.
Headquartered in Richland, Washington, GlobeStar Therapeutics Corporation is a fast-growing company focused on providing medical research, development and treatments for wellness and disease. With a mission to "assist people on their journey to health," GlobeStar Therapeutics also brings high quality supplement products to the market.
"Now that our name change is complete, it's time to let people know who we are and what we are working on," said James C. Katzaroff, President and CEO, GlobeStar Therapeutics Corporation. "This is part of our coming out party with our new name. Our brand is important, and we want NFL fans and collectors to know GlobeStar Therapeutics is a company that is working to meet the challenges associated with Multiple Sclerosis and other neurodegenerative diseases."
In addition to their participation in the Washington Football Team Yearbook, GlobeStar Therapeutics will be launching their new website the week of July 21, 2021. The newly created site will incorporate a full health library, as well as robust details and information on our offerings. Within the health library you will find information on Multiple Sclerosis and other disease, blogs, and a full resource framework for anyone wants to learn more about these challenging neurodegenerative diseases. New content will be added on an ongoing basis.
NOTICE REGARDING FORWARD LOOKING STATEMENTS
This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements that include the words believes, expects, anticipate or similar expressions. Such forward-looking statements involve known and unknown risks, and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
About GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation (OTCBB:GSTC) is a healthcare company dedicated to bringing innovative, effective and high-quality healthcare solutions to the medical community. With a focus on Multiple Sclerosis and other chronic diseases, GlobeStar's team is committed to helping those suffering begin their journey back to health. More information about GlobeStar Therapeutics Corporation can be found at www.angiosoma.com.
Notice Regarding Forward Looking Statements
This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements that include the words "believes," "expects," "anticipate" or similar expressions. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Media Contact:
Brooke Greenwald
Cornerstone Communications, LTD
Brooke@cornerstonepr.net
240-360-0866
SOURCE: AngioSoma, Inc.
View source version on accesswire.com:
https://www.accesswire.com/655635/GlobeStar-Therapeutics-Corporation-To-Be-Seen-In-The-Washington-Football-Team-Yearbook-All-Season
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Formerra Announces Transportation Surcharge to Address Ongoing Freight and Logistics Market Pressures25.3.2026 21:00:00 CET | Press release
CLEVELAND, OH / ACCESS Newswire / March 25, 2026 / Formerra, a leader in performance materials distribution, announced the implementation of a transportation surcharge to address continued cost escalation across the Americas freight and logistics market. Beginning April 1, 2026, a $350 per delivery surcharge will apply to all shipments. The freight and logistics market continues to experience elevated costs driven by rising diesel prices, evolving regulatory requirements affecting driver availability, tighter trucking capacity, and increasing operating expenses across the logistics sector. Industry forecasts indicate these pressures will persist for the foreseeable future. "Maintaining reliable service for our customers requires us to adapt to sustained shifts in the transportation landscape," said Tom Kelly, Formerra CEO. "This surcharge is necessary to address these industrywide cost pressures that are outside of our control while continuing to provide the high service levels custome
Vehicle Tech Week Europe announces Strategic Partnerships with PAVE Europe, ASAM and FISITA, Strengthening its Position as the Global Meeting Point for Future Vehicle Innovation25.3.2026 17:15:00 CET | Press release
STUTTGART, DE / ACCESS Newswire / March 25, 2026 / UKi Media & Events, the organizer of Vehicle Tech Week Europe today announced new strategic partnerships with PAVE Europe (Partners for Automated Vehicle Education), ASAM (Association for Standardization of Automation and Measuring Systems) and FISITA (Fédération Internationale des Sociétés d'Ingénieurs des Techniques de l'Automobile). These alliances reinforce the event's role as a key global hub for the technologies shaping the next era of vehicle mobility. Launching in Stuttgart, Germany, June 23-25, 2026, Vehicle Tech Week Europe brings together three of UKi Media & Events' leading shows - Automotive Testing Expo, Autonomous Vehicle Tech Expo, and Automotive Interiors Expo - into one integrated platform designed to meet the needs of an increasingly convergent industry. Partnerships that broaden expertise and industry alignment PAVE Europe, ASAM and FISITA bring deep experience across engineering, automation, safety, simulation, tes
Lithium Measurement MR-Technology Provider NanoNord Expands Business with DLE Leader ElectraLith, Following Danish State Visit to Australia25.3.2026 13:30:00 CET | Press release
Danish company expands collaboration with Australian deeptech rising star during the Royal State Visit to Melbourne AALBORG, DENMARK AND MELBOURNE, AU / ACCESS Newswire / March 25, 2026 / The North Jutland technology company NanoNord has, in connection with the Royal Couple's state visit to Australia, secured an order for additional measurement equipment valued at between 160k - 240k AUD from the Australian deeptech pioneer ElectraLith. The order underscores the growing international potential for Danish measurement technology in the green transition. NanoNord was part of the business delegation during the state visit and seized the opportunity to strengthen its business with both existing and new customers in Australia. It is not the first time the Danish Royal Family has been close to NanoNord - the company was originally officially inaugurated by a then-young Crown Prince Frederik. Danish Technology Measures Lithium in Real Time NanoNord's flagship technology, Tveskaeg, is an MR-bas
Rancho BioSciences Appoints Chris O'Brien as CEO to Deliver AI-Ready Data Solutions for Faster, More Reliable R&D25.3.2026 13:00:00 CET | Press release
Veteran life sciences leader to drive enterprise growth and expand adoption of AI-ready data solutions across pharma and biotech SAN DIEGO, CA / ACCESS Newswire / March 25, 2026 / Rancho BioSciences today announced the appointment of Chris O'Brien as Chief Executive Officer. O'Brien will lead the company's next phase of growth as Rancho expands adoption of its AI-ready data solutions across pharmaceutical, biotechnology, and research organizations. Rancho BioSciences delivers AI-ready data solutions that transform fragmented biomedical data into standardized, reusable assets for AI, analytics, and machine learning. As life sciences organizations continue investing in AI and advanced analytics, preparing inconsistent and siloed data remains a major bottleneck-often slowing analysis and limiting reuse across programs. Rancho addresses this by standardizing and harmonizing complex data so it can be used immediately and consistently across the R&D lifecycle. O'Brien brings more than 20 yea
Datavault AI Partners with Rising British Heavyweight Moses Itauma25.3.2026 13:00:00 CET | Press release
21-Year-Old Boxing Phenom to Showcase Datavault AI Brand in Manchester Showdown Against Jermaine Franklin PHILADELPHIA, PA / ACCESS Newswire / March 25, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that it has entered into a partnership agreement with undefeated British heavyweight boxing sensation Moses Itauma. The 21-year-old Commonwealth champion's highly anticipated bout against Jermaine Franklin will be on March 28, 2026, at the Co-op Live Arena in Manchester, England, and will be broadcast globally on DAZN. The partnership reflects Datavault AI's strategic focus on elite combat sports talent as the Company builds out its athlete name, image, and likeness ("NIL") digital asset exchange platform, being developed in exploratory collaboration with Sports Illustrated. Itauma (13-0, 11 KOs) is widely regarded as one of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom